Latest Medscape UK News

• Worldwide, Doctors Report Harassment — and Inaction Doctors report mental health effects, isolation, and even quitting their jobs — yet perpetrators rarely face consequences.
  Medscape Medical News, April 11, 2025
• Does AI Improve Paediatric Fracture Detection? A deep learning–based tool shows a high accuracy of fracture detection in children and may boost the diagnostic skills of emergency department residents, a real-world study suggests.
  Medscape News UK, April 11, 2025
• Anaemia in Children With IBD: A Persistent Challenge A significant proportion of children newly diagnosed with IBD present with anaemia, and many of them remain anaemic even after a year, warranting adequate attention to the issue.
  Medscape News UK, April 11, 2025
• Quetiapine Outperforms Lithium in Resistant Depression Quetiapine augmentation outperforms lithium augmentation in long-term clinical and cost-effectiveness among adults with treatment-resistant depression, a 52-week trial finds.
  Medscape News UK, April 11, 2025
• Alert NICE Recommends Capivasertib for Advanced Breast Cancer The targeted drug capivasertib will be available immediately for some patients in England with advanced breast cancer.
  Medscape News UK, April 11, 2025
• Popular Joint Supplement Cuts Nephropathy Risk in T2D People with type 2 diabetes who regularly use the supplement glucosamine have a lower risk for microvascular complications and diabetic nephropathy, a prospective observational study finds.
  Medscape Medical News, April 11, 2025
• Alert NICE Backs Oral Drug for Advanced Bladder Cancer NICE has approved the oral drug erdafitinib for adults with advanced urothelial cancer and FGFR3 alterations, offering new hope and home-based treatment.
  Medscape News UK, April 10, 2025
• Can Shorter Antibiotic Treatment Benefit Kids With UTIs? Individualised antibiotic treatment increases the risk for recurrence but reduces antibiotic use and the number of adverse event days in children with febrile UTIs, a Danish trial reveals.
  Medscape News UK, April 10, 2025
• Inflammatory Marker Predicts Liver Cancer Risk in T2D An inflammatory biomarker, YKL-40, serves as a reliable prognostic marker for liver and bladder cancers in patients with newly diagnosed T2D, outperforming CRP for these cancers.
  Medscape News UK, April 10, 2025
• Novel JAK Inhibitor Improves QOL in Chronic Hand Eczema Treatment with delgocitinib cream leads to improvement in health-related quality of life in patients with moderate to severe chronic hand eczema, according to a phase 2b trial.
  Medscape News UK, April 10, 2025
• NICE Urges Reform of ‘Inconsistent’ Neuro Rehab Services Draft guidance addresses ‘widespread’ disparities in neurological rehabilitation in England and urged better coordination and holistic patient care.
  Medscape News UK, April 10, 2025
• Cancer Deaths Fall in Europe, but Not Across All Types A new study has revealed significant reductions in cancer deaths across Europe, yet critical challenges persist for specific tumour types.
  Medscape News UK, April 10, 2025
• Sensory-Impaired Patients Face Medication Safety Risks Patients with vision or hearing impairments face a lack of accessible information when using medicines and medical devices, the Patient Safety Commissioner for England has warned.
  Medscape News UK, April 09, 2025
• Switching to Budesonide Tablet Shows Promise in EoE Budesonide orodispersible tablets show effectiveness in treating patients with eosinophilic oesophagitis after switching from off-label swallowed topical corticosteroids, a study shows.
  Medscape News UK, April 09, 2025
• Liberal Blood Transfusions Don't Cut Hypoxaemia in Preemies A study shows that in infants with birthweight < 1000 g, liberal vs restrictive blood transfusion does not reduce intermittent hypoxaemia or improve neurocognitive outcomes.
  Medscape News UK, April 09, 2025
• Magnetic Brain Stimulation Shows Promise in Alzheimer's Care Personalised magnetic stimulation of the precuneus over 52 weeks slows cognitive and functional decline compared with sham in mild to moderate Alzheimer's, a trial shows.
  Medscape News UK, April 09, 2025
• Dropout Rate Raises Questions on NHS Talking Therapies Referrals to NHS Talking Therapies have soared, but with only 37% completing treatment, experts have questioned the service’s structure and outcomes.
  Medscape News UK, April 08, 2025
• Hypertensive Pregnancy Increases Dilated Cardiomyopathy Risk Hypertensive disorders of pregnancy in first pregnancies double the risk for dilated cardiomyopathy, with the onset earlier than that in normotensive pregnancies.
  Medscape News UK, April 08, 2025
• Popular Urine Test Predicts Death Risk in Adrenal Adenomas This is the first study to demonstrate that 24 h-urine levels of normetanephrine serves as a consistent independent predictor of overall mortality in patients with adrenal adenomas.
  Medscape News UK, April 08, 2025
• Delayed STEMI Care Linked to Reduced Heart Function The risk for reduced left ventricular ejection fraction is higher in patients with STEMI receiving delayed reperfusion than in those receiving timely reperfusion, a study finds.
  Medscape News UK, April 08, 2025